152 related articles for article (PubMed ID: 38432677)
1. [Establishment and application of intrahepatic cholangiocarcinoma organoid models].
Liu Y; Liang X
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):346-352. PubMed ID: 38432677
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
[TBL] [Abstract][Full Text] [Related]
3. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
4. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer.
De Siervi S; Turato C
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901961
[TBL] [Abstract][Full Text] [Related]
5. Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.
Sato K; Zhang W; Safarikia S; Isidan A; Chen AM; Li P; Francis H; Kennedy L; Baiocchi L; Alvaro D; Glaser S; Ekser B; Alpini G
Hepatology; 2021 Jul; 74(1):491-502. PubMed ID: 33222247
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system.
Saito Y; Nakaoka T; Muramatsu T; Ojima H; Sukeda A; Sugiyama Y; Uchida R; Furukawa R; Kitahara A; Sato T; Kanai Y; Saito H
Sci Rep; 2018 Feb; 8(1):2821. PubMed ID: 29434290
[TBL] [Abstract][Full Text] [Related]
7. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.
Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S
Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
10. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
Vaeteewoottacharn K; Pairojkul C; Kariya R; Muisuk K; Imtawil K; Chamgramol Y; Bhudhisawasdi V; Khuntikeo N; Pugkhem A; Saeseow OT; Silsirivanit A; Wongkham C; Wongkham S; Okada S
Cells; 2019 May; 8(5):. PubMed ID: 31126020
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids.
Amato F; Rae C; Prete MG; Braconi C
Cells; 2020 Mar; 9(4):. PubMed ID: 32235647
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.
Aishima S; Oda Y
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):94-100. PubMed ID: 25181580
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.
Lee KB
Clin Mol Hepatol; 2016 Sep; 22(3):400-405. PubMed ID: 27729636
[TBL] [Abstract][Full Text] [Related]
14. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
[TBL] [Abstract][Full Text] [Related]
15. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
[TBL] [Abstract][Full Text] [Related]
16. Label-Free Imaging Analysis of Patient-Derived Cholangiocarcinoma Organoids after Sorafenib Treatment.
Koch M; Nickel S; Lieshout R; Lissek SM; Leskova M; van der Laan LJW; Verstegen MMA; Christ B; Pampaloni F
Cells; 2022 Nov; 11(22):. PubMed ID: 36429040
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings.
Han JK; Choi BI; Kim AY; An SK; Lee JW; Kim TK; Kim SW
Radiographics; 2002; 22(1):173-87. PubMed ID: 11796906
[TBL] [Abstract][Full Text] [Related]
18. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional printing model of liver for operative simulation in perihilar cholangiocarcinoma.
Takagi K; Nanashima A; Abo T; Arai J; Matsuo N; Fukuda T; Nagayasu T
Hepatogastroenterology; 2014; 61(136):2315-6. PubMed ID: 25699373
[TBL] [Abstract][Full Text] [Related]
20. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]